ENTEROCOQUES RESISTANTS A LA VANCOMYCINE ET LE ROLE DU TRAVAILLEUR DE SANTE
Résumé
Depuis la dernière décennie, la croissance de la résistance aux antibiotiques est fulgurante, et la propagation de souches résistantes aux antibiotiques est maintenant devenue une menace dans les hôpitaux. Les entérocoques résistants à la vancomycine (ERV) se sont révélés une de ces souches. Le ERV est un micro-organisme robuste capable de survivre longtemps sur les surfaces. Ils sont rapidement transmis de patient à patient par le contact avec les travailleurs de santé. Cette souche peut croître le taux de mortalité des patients dont le système immunitaire est affaibli. Les travailleurs de santé dans les hôpitaux ont un rôle primordial à jouer dans la prévention et le contrôle du ERV. Se laver fréquemment les mains en employant une bonne technique est une manière efficace de prévenir et à contrôler la propagation du ERV. Fournir une formation et des ressources aux travailleurs de santé est aussi un facteur important. La théorie des croyances aide à expliquer comment approcher et appliquer les changements à la pratique.
Références
World Health Organization, Overcoming
antimicrobial resistance. Report on Infectious
Diseases 2000 [serial on the Internet]. 2000 [cited
May 17]. Available from: www.who.int/
infectious-disease-report/2000/index.html.
Conly, J, “Antimicrobial resistance in Canada”
Canadian Medical Association Journal.
8(2002) : 885-891.
Lior, L, Litt, M, Hockin, J, Kennedy, C, Jolley,
BA, Garcia, M et al. “Vancomycin-resistant
enterococci on a renal ward in an Ontario
hospital” Canada Communicable Disease Report.
15 (1996) : 125-8.
Sample, M., Gravel, D., Oxley, C., Toye, B.,
Garber, D., Ramotar, K., “An outbreak of
vancomycin-resistant enterococci in a
hematology-oncology unit: control by patient
cohorting and terminal cleaning environment”
Infection Control and Hospital Epidemiology.
8 (2002) : 468-471.
Mayhall, C., “Control of vancomycin-resistant
enterococci: it is important, it is possible, and it is
cost-effective” Infection Control and Hospital
Epidemiology. 23.8 (2002) : 420-424.`
Manitoba Health. “Vancomycin Resistant
Enterococci: Communicable Disease Management
Protocol” [serial on the Internet]. 2001 [cited
May 27]. Available from http://www.gov.
mb.ca/health/publichealth/cdc/protocol/vre.pdf
Smeltzer, S., Bare, B., Medical-Surgical
Nursing. 9th ed. (Philadelphia: Lippincott
Williams and Wilkins 2000).
Springhouse Corporation, Handbook of
Medical-Surgical Nursing. 3rd ed. (Philadelphia:
Lippincott Williams and Wilkins 2002).
Boyce, J., “Vancomycin-resistant enterococci:
pervasive and persistent pathogens” Infection
Control and Hospital Epidemiology. 16.12
(1995) : 676-679.
Bonten, M., Hayden, M.K., Nathan, C., Van
Vorhis, J., Matusheik, M., Slaughter, S., et al,
”Epidemiology of colonization of patients and
environment with vancomycin-resistant
enterococci” Lancet. 348 (1996) : 1615-1619.
Saloojee, H., Steenhoff, A., “The health
professional’s role in preventing nosocomial
infections” Postgraduate Medical Journal
903(2000) : 16-19.
Wenzel, R., Edmond, M., “Managing
antibiotic resistance” New England Journal of
Medicine. 343.26 (2000) : 1961-1963.
Canadian Bacterial Surveillance Network,
MRSA and VRE -The Ontario Experience. 2002
[cited 2005 May 20]. Available from
http://microbiology.mtsinai.on.ca/research/cbsnne
ws/may02-news.pdf
Harbarth, S., Samore, M. “Antimicrobial
resistance determinants and future control”
Emerging Infectious Diseases. 11.6 (2005) : 794-
Lee, T., Hacck, D., Stroupe, K., Collins, S.,
Peterson, L., “Three surveillance strategies for
vancomycin-resisitant enterococci in hospitalized
patients: detection of colonization efficiency and
a cost-effectiveness model” Infection Control and
Hospital Epidemiology. 26.1 (2005) : 39-46.
Byers, K.E., Anglin, A.M., Anneski, C.J.,
Gemanson, T.P., Gold, H.S., Durbin, L.J., et al,
“A hospital epidemic of vancomycin-resistant
enterococcus: risk factors and control” Infection
Control and Hospital Epidemiology. 22.3 (2001)
: 140-147.
Centre for Disease Control and Prevention
(CDC). Issues in Healthcare Setting; c1999 [cited
May 17]. Available from:
www.cdc.gov/ncidod/hip/Lab/FactSheet/vre.htm.
Anonymous, “Orthopedic surgeons approve
statement on vancomycin use” Association of
Operating Room Nurses Journal. 68.5 (1998) :
Ott, M., Shen, J., Sherwood, S., “Evidencebased
practice for control of Methicilin-resistant
staphylococcus aureus” Association of Operating
Room Nurses Journal. 81.2 (2005) : 359, 361-4,
, 369-72.
Davies, H., Rees, J., “Psychological effects of
isolation nursing (1): mood disturbance” Nursing
Standard. 14.28 (2000) : 35-38.
Centre for Disease Control and Prevention
(CDC), Hand Hygiene Fact Sheet; c2002 [cited
May 17]. Available from: http://www.cdc.
gov/od/oc/media/pressrel/fs021025.htm.
Gould, D., Wilson-Barnett, J., Ream, E.,
“Nurses infection-control practices: hand
decontamination, the use of gloves and sharp
instruments” International Journal of Nursing
Studies. 33.2 (1996) : 143-160.
Tibballs, J., “Teaching hospital medical staff
to handwash” Medical Journal of Australia. 164
(1996) : 395-398.
Boyce, J., “It is time for action: improving
hand hygiene in hospitals” Annals of Internal
Medicine. 130.2 (1999) : 153-155.
College of Nurses of Ontario (CNO),
Infection control guidelines. (Toronto: College of
Nurses of Ontario 1999).
Community and Hospital Infection Control
Association (CHICA), Global Consensus
Conference; c1999 [cited 2005 May 16].
Available from: www.chica.org.gcc.html.
